iifl-logo

Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Nifty Pharma ETF

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Exchange Traded Funds (ETFs)

Launch Date

21-Jun-2021

Fund Manager

Jitendra Tolani

Net Assets (Rs. cr)

1026.5

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nippon India Nifty Pharma ETF - Nav Details

Nav Date

:  12-Jan-2026

NAV [Rs.]

:  23.2156

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

Nil

Nippon India Nifty Pharma ETF- NAV Chart

Nippon India Nifty Pharma ETF- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-0.33
-0.63
1.98
2.1
1.78
21.97
-
11.11
Category Avg
-1.11
1.99
6.07
12.86
22.56
19.82
15.05
16.35
Category Best
9.03
32.03
75.31
133.66
180.3
53.69
35.74
212.16
Category Worst
-5.9
-6.24
-9.48
-12.72
-12.96
7.23
5.09
-23.31

Nippon India Nifty Pharma ETF- Latest Dividends

No Records Found

Nippon India Nifty Pharma ETF- Investment Details

Min. Investment(Rs.)

1000

Increm.Investment(Rs.)

0

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology22.051316295226.36
EquityCiplaPharmaceuticals & Biotechnology10.30699411105.70
EquityDivi's Lab.Pharmaceuticals & Biotechnology9.84157975100.98
EquityDr Reddy's LabsPharmaceuticals & Biotechnology9.3875770196.33
EquityLupinPharmaceuticals & Biotechnology6.1930130363.55
EquityLaurus LabsPharmaceuticals & Biotechnology5.2148295253.51
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.8813014750.10
EquityAurobindo PharmaPharmaceuticals & Biotechnology4.0134766341.12
EquityAlkem LabPharmaceuticals & Biotechnology3.907267040.01
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology3.7118725738.11
EquityMankind PharmaPharmaceuticals & Biotechnology3.0114065230.89
EquityBioconPharmaceuticals & Biotechnology2.8674635629.39
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.7731108128.44
EquityIpca Labs.Pharmaceuticals & Biotechnology2.3917270824.50
EquityAbbott IndiaPharmaceuticals & Biotechnology1.83647118.78
EquityJ B Chemicals &Pharmaceuticals & Biotechnology1.8010159518.48
EquityGland PharmaPharmaceuticals & Biotechnology1.669896217.04
EquityWockhardtPharmaceuticals & Biotechnology1.4510263214.84
EquityAjanta PharmaPharmaceuticals & Biotechnology1.415238214.50
EquityPiramal PharmaPharmaceuticals & Biotechnology1.2976920513.24

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,11,597.56
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.